FINAL RESULTS FROM THE AXIG TRIAL: A RANDOMIZED PHASE II CLINICAL TRIAL INVESTIGATING AXITINIB ALONE OR IN COMBINATION WITH CCNU IN PATIENTS WITH RECURRENT GLIOBLASTOMA

被引：0
|
作者：
Duerinck, Johnny [1 ]
Du Four, Stephanie [1 ]
Bouttens, Frank [2 ]
Verschaeve, Vincent [3 ]
Chaskis, Cristo [9 ]
Andre, Chantal [4 ]
Van Fraeyenhove, Frank [5 ]
D'haene, Nicky [6 ]
Salmon, Isabelle [7 ]
Neyns, Bart [8 ]
机构：
[1] Uz Brussel, Dept Neurosurg, Brussels, Belgium
[2] Az Sint Lucas, Dept Radiotherapy, Ghent, Belgium
[3] GhDC, Dept Med Oncol, Charleroi, Belgium
[4] CHU ULG, Dept Med Oncol, Liege, Belgium
[5] ZNA Middelheim, Dept Med Oncol, Antwerp, Belgium
[6] Erasmus Hosp, Dept Pathol, Brussels, Belgium
[7] Erasmus Hosp, Dept Pathol, Brussels, Belgium
[8] Uz Brussel, Dept Med Oncol, Brussels, Belgium
[9] CHU, Dept Neurosurg, Charleroi, Charleroi, Belgium
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ACTR-29
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS TTFIELDS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): DATA FROM A PHASE II CLINICAL TRIAL
    Fallah, Jaleh
    Chaudhary, Rekha
    Rogers, Lisa
    Wei, Wei
    Brewer, Cathy
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2019, 21 : 18 - 18
  • [42] Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial
    Klein, Allan L.
    Lin, David
    Cremer, Paul C.
    Nasir, Saifullah
    Luis, Sushil Allen
    Abbate, Antonio
    Ertel, Andrew
    LeWinter, Martin
    Beutler, Anna
    Fang, Fang
    Paolini, John F.
    HEART, 2021, 107 (06) : 488 - 496
  • [43] Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
    Izumoto, Shuichi
    Tsuboi, Akihiro
    Oka, Yoshihiro
    Suzuki, Tsuyoshi
    Hashiba, Tetsuo
    Kagawa, Naoki
    Hashimoto, Naoya
    Maruno, Motohiko
    Elisseeva, Olga A.
    Shirakata, Toshiaki
    Kawakami, Manabu
    Oji, Yusuke
    Nishida, Sumiyuki
    Ohno, Satoshi
    Kawase, Ichiro
    Hatazawa, Jun
    Nakatsuka, Shin-icih
    Aozasa, Katsuyuki
    Morita, Satoshi
    Sakamoto, Junichi
    Sugiyama, Haruo
    Yosihmine, Toshiki
    JOURNAL OF NEUROSURGERY, 2008, 108 (05) : 963 - 971
  • [44] Phase II trial of intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma
    Ursu, R.
    Carpentier, A.
    Metellus, P.
    Barrie, M.
    Meng, Y.
    Laigle-Donadey, F.
    Tibi, A.
    Chinot, O.
    Carpentier, A. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
    Peters, Katherine B.
    Vredenburgh, James J.
    Desjardins, Annick
    Friedman, Henry S.
    Herndon, James Emmett
    Coan, April D.
    McSherry, Frances
    Lipp, Eric S.
    Brickhouse, Alise
    Massey, Woody C.
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] A phase II trial of lapatinib and pazopanib for patients with recurrent glioblastoma multiforme (GBM)
    Reardon, David
    Groves, Morris
    Wen, Patrick
    Nabors, Louis
    Mikkelsen, Tom
    Rosenfeld, Steve
    Harris, Dean
    DeMarini, Douglas
    Suttle, Ben
    Arumugham, Thangam
    Hodge, Jeffrey
    Lager, Joanne
    NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
  • [47] Phase II trial of irinotecan and thalidomide in adult patients with recurrent glioblastoma multiforme
    Puduvalli, V. K.
    Giglio, P.
    Groves, M. D.
    Hess, K. R.
    Gilbert, M. R.
    Mahankali, S.
    Jackson, E.
    Levin, V. A.
    Conrad, C. A.
    Hsu, S.
    Colman, H.
    Ritterhouse, M.
    Ichtech, S.
    Yung, W. K. A.
    NEURO-ONCOLOGY, 2006, 8 (04) : 450 - 450
  • [48] A PHASE II TRIAL OF SORAFENIB (NEXAVAR) AND PROTRACTED TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT GLIOBLASTOMA
    Reardon, David
    Desjardins, Annick
    Vredenburgh, James
    Friedman, Allan
    Sampson, John
    Gururangan, Sridharan
    Rich, Jeremy
    Friedman, Henry
    NEURO-ONCOLOGY, 2008, 10 (05) : 839 - 839
  • [49] FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM
    Brandes, Alba A.
    Finocchiaro, Gaetano
    Zagonel, Vittorina
    Reni, Michele
    Fabi, Alessandra
    Caserta, Claudia
    Clavarezza, Matteo
    Maiello, Evaristo
    Carteni, Giacomo
    Rosti, Giovanni
    Eoli, Marica
    Lombardi, Giuseppe
    Monteforte, Marta
    Agati, Raffaele
    Eusebi, Vincenzo
    Galli, Anna
    Doria, Simona
    Franceschi, Enrico
    NEURO-ONCOLOGY, 2014, 16
  • [50] Phase II clinical trial of axitinib in metastatic pheochromocytomas and paraganlgiomas (P/PG): Preliminary results
    Pichun, Mauricio Emmanuel Burotto
    Edgerly, Maureen
    Velarde, Margarita
    Bates, Susan Elaine
    Daerr, Roland
    Adams, Karen
    Pacak, Karel
    Fojo, Tito
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345